
Join to View Full Profile
975 Sereno DrVallejo, CA 94589
Phone+1 707-651-1000
Dr. Kolevska is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1999 - 2002
- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1996 - 1999
- University of Zagreb Faculty of MedicineClass of 1986
Certifications & Licensure
- CA State Medical License 2002 - 2026
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer Start of enrollment: 2005 Aug 01
- Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
- PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery Start of enrollment: 2012 Jun 12
- Join now to see all
Publications & Presentations
PubMed
- Endocrine therapy and risk of cardiovascular disease and mortality in postmenopausal breast cancer survivors.Yuhan Huang, Marilyn L Kwan, Susan R Heckbert, Nicholas L Smith, Megan Othus
Journal of the National Cancer Institute. 2025-03-11 - Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing Study.Peng Wang, Kelli O'Connell, Jenna Bhimani, Victoria Blinder, Rachael Burganowski
JCO Clinical Cancer Informatics. 2025-02-01 - Duration of aromatase inhibitor use and long-term cardiovascular risk in breast cancer survivors.Yuhan Huang, Marilyn L Kwan, Susan R Heckbert, Nicholas L Smith, Megan Othus
JNCI Cancer Spectrum. 2025-01-03
Press Mentions
- Research Finds Cancer Patients Often Do Better with Less Intensive TreatmentDecember 8th, 2024
- How the Telehealth Revolution Is Transforming Cancer CareOctober 10th, 2024
- Tech, Collaboration Can Mitigate Major Health Care ChallengesNovember 14th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: